Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:39 UTC |
---|
HMDB ID | HMDB0014539 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Carisoprodol |
---|
Description | Carisoprodol, also known as soma or isoprotane, belongs to the class of organic compounds known as carbamate esters. Carbamate esters are compounds containing an ester of carbamic acid with the general structure R2NC(=O)OR' (R' not H). They are esters of carbamic acids. Based on a literature review a small amount of articles have been published on Carisoprodol. |
---|
Structure | CCCC(C)(COC(N)=O)COC(=O)NC(C)C InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16) |
---|
Synonyms | Value | Source |
---|
(+-)-2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate | ChEBI | (1-Methylethyl)carbamic acid 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester | ChEBI | 2-Methyl-2-propyl-1,3-propanediol carbamate isopropylcarbamate | ChEBI | 2-Methyl-2-propyltrimethylene carbamate isopropylcarbamate | ChEBI | Carbamic acid 2-isopropylcarbamoyloxymethyl-2-methyl-pentyl ester | ChEBI | Carisoprodolum | ChEBI | Isopropyl meprobamate | ChEBI | N-Isopropy-2-methyl-2-propyl-1,3-propanediol dicarbamate | ChEBI | Soma | Kegg | (+-)-2-Methyl-2-propyl-1,3-propanediol carbamic acid isopropylcarbamic acid | Generator | (1-Methylethyl)carbamate 2-(((aminocarbonyl)oxy)methyl)-2-methylpentyl ester | Generator | 2-Methyl-2-propyl-1,3-propanediol carbamic acid isopropylcarbamic acid | Generator | 2-Methyl-2-propyltrimethylene carbamic acid isopropylcarbamic acid | Generator | Carbamate 2-isopropylcarbamoyloxymethyl-2-methyl-pentyl ester | Generator | Isopropyl meprobamic acid | Generator | N-Isopropy-2-methyl-2-propyl-1,3-propanediol dicarbamic acid | Generator | Carisoprodate | HMDB | Carisoprodatum | HMDB | Isomeprobamate | HMDB | Isoprotane | HMDB | Isoprothane | HMDB | Isopropylmeprobamate | HMDB | Mio relax | HMDB | Schein brand OF carisoprodol | HMDB | Somalgit | HMDB | Soprodol | HMDB | Vanadom | HMDB | Wallace brand 1 OF carisoprodol | HMDB | Belmac brand OF carisoprodol | HMDB | Carisoma | HMDB | Forest brand OF carisoprodol | HMDB | GM Pharmaceuticals brand OF carisoprodol | HMDB | Isobamate | HMDB | Carter horner brand OF carisoprodol | HMDB | Wallace brand 2 OF carisoprodol | HMDB | Wallace brand 3 OF carisoprodol | HMDB |
| Show more...
---|
Chemical Formula | C12H24N2O4 |
---|
Average Molecular Weight | 260.33 |
---|
Monoisotopic Molecular Weight | 260.173607266 |
---|
IUPAC Name | 2-[(carbamoyloxy)methyl]-2-methylpentyl N-(propan-2-yl)carbamate |
---|
Traditional Name | Soma |
---|
CAS Registry Number | 78-44-4 |
---|
SMILES | CCCC(C)(COC(N)=O)COC(=O)NC(C)C |
---|
InChI Identifier | InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16) |
---|
InChI Key | OFZCIYFFPZCNJE-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as carbamate esters. Carbamate esters are compounds containing an ester of carbamic acid with the general structure R2NC(=O)OR' (R' not H). They are esters of carbamic acids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Carbamate esters |
---|
Alternative Parents | |
---|
Substituents | - Carbamic acid ester
- Carbonic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 92 - 93 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.79 g/L | Not Available | LogP | 2.1 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Carisoprodol,1TMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C | 1990.9 | Semi standard non polar | 33892256 | Carisoprodol,1TMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C | 1956.5 | Standard non polar | 33892256 | Carisoprodol,1TMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C | 2590.3 | Standard polar | 33892256 | Carisoprodol,1TMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C | 1978.9 | Semi standard non polar | 33892256 | Carisoprodol,1TMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C | 1898.2 | Standard non polar | 33892256 | Carisoprodol,1TMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C | 2951.2 | Standard polar | 33892256 | Carisoprodol,2TMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C | 2056.0 | Semi standard non polar | 33892256 | Carisoprodol,2TMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C | 2040.5 | Standard non polar | 33892256 | Carisoprodol,2TMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C | 2337.0 | Standard polar | 33892256 | Carisoprodol,2TMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2057.1 | Semi standard non polar | 33892256 | Carisoprodol,2TMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2048.3 | Standard non polar | 33892256 | Carisoprodol,2TMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2378.5 | Standard polar | 33892256 | Carisoprodol,3TMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2089.4 | Semi standard non polar | 33892256 | Carisoprodol,3TMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2148.2 | Standard non polar | 33892256 | Carisoprodol,3TMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C)COC(=O)N([Si](C)(C)C)[Si](C)(C)C | 2151.1 | Standard polar | 33892256 | Carisoprodol,1TBDMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C(C)(C)C | 2205.6 | Semi standard non polar | 33892256 | Carisoprodol,1TBDMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C(C)(C)C | 2124.0 | Standard non polar | 33892256 | Carisoprodol,1TBDMS,isomer #1 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N[Si](C)(C)C(C)(C)C | 2623.7 | Standard polar | 33892256 | Carisoprodol,1TBDMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2225.9 | Semi standard non polar | 33892256 | Carisoprodol,1TBDMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2119.0 | Standard non polar | 33892256 | Carisoprodol,1TBDMS,isomer #2 | CCCC(C)(COC(N)=O)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2955.3 | Standard polar | 33892256 | Carisoprodol,2TBDMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C(C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2505.2 | Semi standard non polar | 33892256 | Carisoprodol,2TBDMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C(C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2389.0 | Standard non polar | 33892256 | Carisoprodol,2TBDMS,isomer #1 | CCCC(C)(COC(=O)N[Si](C)(C)C(C)(C)C)COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C | 2526.8 | Standard polar | 33892256 | Carisoprodol,2TBDMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2514.5 | Semi standard non polar | 33892256 | Carisoprodol,2TBDMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2410.0 | Standard non polar | 33892256 | Carisoprodol,2TBDMS,isomer #2 | CCCC(C)(COC(=O)NC(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2530.4 | Standard polar | 33892256 | Carisoprodol,3TBDMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2758.1 | Semi standard non polar | 33892256 | Carisoprodol,3TBDMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2677.9 | Standard non polar | 33892256 | Carisoprodol,3TBDMS,isomer #1 | CCCC(C)(COC(=O)N(C(C)C)[Si](C)(C)C(C)(C)C)COC(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2484.9 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Carisoprodol EI-B (Non-derivatized) | splash10-0a4i-9200000000-7ee2bc67a583d40d99b8 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Carisoprodol EI-B (Non-derivatized) | splash10-0a4i-9200000000-7ee2bc67a583d40d99b8 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Carisoprodol GC-MS (Non-derivatized) - 70eV, Positive | splash10-052f-9320000000-ea5623d29b47a08ec316 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Carisoprodol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Carisoprodol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0a4l-9200000000-84ceb4ca447a62939b63 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-qTof , Positive-QTOF | splash10-056r-1920000000-df362ad4c912b7d0fb43 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-004i-4910000000-0fe5eef3c39360c36d38 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-01ot-9300000000-94d7b1adea0d831c0950 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-03dj-9100000000-a99d65f53726ca3b6116 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-03di-9000000000-618eb5a23da29ec51cb6 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-03di-9000000000-d2d07fc2a5972fd4e9f8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol LC-ESI-QFT , positive-QTOF | splash10-03di-9000000000-007521fa65c254bad2b6 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol , positive-QTOF | splash10-056r-1920000000-df362ad4c912b7d0fb43 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 90V, Positive-QTOF | splash10-03di-9000000000-bf1fe057c44420039b3a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 15V, Positive-QTOF | splash10-004i-4910000000-e7f506802140a9e5d5f6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 45V, Positive-QTOF | splash10-03dj-9100000000-ab0f09b2ddbd1ef81090 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 30V, Positive-QTOF | splash10-01ot-9300000000-1ebfa5d842a1f8d54673 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 60V, Positive-QTOF | splash10-03di-9000000000-ef44fb81f70af0bfd465 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Carisoprodol 75V, Positive-QTOF | splash10-03di-9000000000-a7cb3ad99f7b8bfb6ed9 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 10V, Positive-QTOF | splash10-03di-6490000000-046fd220fa245140ddab | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 20V, Positive-QTOF | splash10-0a4i-9320000000-b08ca9d93b628ea8b4f3 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 40V, Positive-QTOF | splash10-052f-9100000000-4f09dfa1c188e3251a65 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 10V, Negative-QTOF | splash10-000x-9010000000-548142f811b5a3632f8d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 20V, Negative-QTOF | splash10-0006-9000000000-37215ebd46867ac40f9f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 40V, Negative-QTOF | splash10-052f-9100000000-46650c3ec5dedc27b7ec | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 10V, Positive-QTOF | splash10-0lxt-7970000000-bf2aa9b29774479d4c05 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 20V, Positive-QTOF | splash10-0f6t-9410000000-9352c9b82fc7d1079dd7 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 40V, Positive-QTOF | splash10-03ec-9100000000-c1581d5627d6283a4fbf | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 10V, Negative-QTOF | splash10-0adi-2960000000-0132a40d2da121a22471 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carisoprodol 20V, Negative-QTOF | splash10-003r-3900000000-5ed690941e48fd4fa317 | 2021-09-24 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00395 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00395 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00395 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | C00032142 |
---|
Chemspider ID | 2478 |
---|
KEGG Compound ID | C07927 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Carisoprodol |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 2576 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 3419 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Littrell RA, Hayes LR, Stillner V: Carisoprodol (Soma): a new and cautious perspective on an old agent. South Med J. 1993 Jul;86(7):753-6. [PubMed:8322081 ]
- Chou R, Peterson K, Helfand M: Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage. 2004 Aug;28(2):140-75. [PubMed:15276195 ]
- Toth PP, Urtis J: Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther. 2004 Sep;26(9):1355-67. [PubMed:15530999 ]
|
---|